Eveready Inds.
Eveready Inds. Q4 FY26 Results & Concall Highlights: Revenue, Margins & Order Book
Q4 FY26 earnings call: what management guided on revenue, margins and order book.
The short version
Alkaline battery volumes expected to double, growing at over 20% CAGR, becoming 1/3 of the overall battery segment in India over 5-10 years (Page 6, 12, 13). FY '26 saw revenue growth of 8.2% and EBITDA growth of 8.9%, with an 11.5% EBITDA margin.
From Eveready Inds.'s Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Alkaline battery volumes expected to double, growing at over 20% CAGR, becoming 1/3 of the overall battery segment in India over 5-10 years (Page 6, 12, 13).
- Zinc battery volumes expected to remain flat or grow low single digits; some cannibalization by alkaline segment anticipated (Page 12, 13).
- Flashlight and lighting segment showed steady growth (~3% to 8.1%) with focus on premium/rechargeable products; expected to contribute about 12%-23% of total mix; growth sustained and considered sustainable (Page 4, 10, 13).
- Jammu alkaline battery plant to ramp up to ~30% utilization by year-end, producing 100+ million units in first year, supporting growth, margins, and market share (Page 4, 5, 6).
- Adjacent categories like mosquito racquets, power banks, and chargers expected to expand (Page 4).
- Overall volume drivers remain alkaline batteries and premiumization across categories (Page 13).
- FY '27 seen as an important year of optimization with growth acceleration (Page 4).
Profitability & Margins
See what Eveready Inds. said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
Top-ranked in Household Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Eveready Inds. said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
Eveready Inds. — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹327 Cr, net profit ₹142 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Eveready Industries India Ltd's management said in earlier quarters
Others in Household Products this season
- Jyothy Labs Ltd (Q4 FY26)
The company has taken a calibrated 4% price increase in March, with further pricing actions planned depending on input cost trends (Page 11-16). Key concall…
- Flair Writing Industries Ltd (Q4 FY26)
Expansion of manufacturing capacity with new facilities (Valsad, Surat) supporting increased production, enabling peak revenue capacity of approximately…
- Linc Ltd (Q4 FY26)
Operating EBITDA margin for FY26 was 11%, with a slight decline; Q4 FY26 margin improved to 12.9%. Key concall takeaways from Linc Ltd's Q4 FY26 earnings call…
- Navneet Education Ltd (Q4 FY26)
Brand investment of INR 30-40 crores over two years to drive long-term sustainable growth, particularly in domestic stationery. Key concall takeaways from…
Frequently Asked Questions
What were Eveready Inds. Q4 FY26 results?
Alkaline battery volumes expected to double, growing at over 20% CAGR, becoming 1/3 of the overall battery segment in India over 5-10 years (Page 6, 12, 13). FY '26 saw revenue growth of 8.2% and EBITDA growth of 8.9%, with an 11.5% EBITDA margin.
What is Eveready Inds. share price analysis?
Eveready Inds. currently shows a neutral. The stock trades at a P/E of 16.3 with a market cap of ₹2,591 Cr. Investors should review the full earnings analysis for detailed insights.
Is Eveready Inds. planning capital expenditure?
The Jammu facility, which is the only alkaline battery plant in India, was commissioned recently with commercial production starting shortly; it supports manufacturing of alkaline batteries, zinc batteries, flashlights, and lighting products.
Keep Eveready Inds. on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
